Hematología

2022

1. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

   Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

2. Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry

   Leukemia Research, Vol. 115

3. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

   Bone Marrow Transplantation, Vol. 57, Núm. 3, pp. 416-422

4. Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

   Cancers, Vol. 14, Núm. 9

5. Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection

   Blood Coagulation and Fibrinolysis, Vol. 33, Núm. 6, pp. 342-347

6. Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

   Cancers, Vol. 14, Núm. 11

7. Comparison of transfusion-outcome in patients with massive bleeding receiving pathogen-reduced platelets prepared with two different technologies

   Transfusion and Apheresis Science, Vol. 61, Núm. 3

8. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

   New England Journal of Medicine, Vol. 386, Núm. 1, pp. 11-23

9. Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

   Frontiers in Oncology, Vol. 12

10. Frozen and cold-stored platelets: reconsidered platelet products

    Platelets, Vol. 33, Núm. 1, pp. 27-34

11. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

    International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392

12. IX international curse of continuing formation in haemophilia and other congenital coagulopathies. The role of the Laboratory in coagulation disorders. Diagnosis of von Willebrand disease

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Vol. 33, pp. S12-S14

13. Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis

    Frontiers in Oncology, Vol. 12

14. Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1369-1378

15. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2231-2239

16. Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era

    Annals of Hematology, Vol. 101, Núm. 1, pp. 59-67

17. Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products

    Thrombosis Research, Vol. 216, pp. 35-42

18. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC

    Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10

19. Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis

    British Journal of Haematology, Vol. 199, Núm. 4, pp. 529-538

20. Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

    HemaSphere, Vol. 6, Núm. 4